SGP
SpyGlass Pharma, Inc.
34.97
+0.79 (+2.31%)
52w low 17.06
39.92 high
78.3% of range
Financial Analysis
| Ratio | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Returns | ||||
| Return on Equity | 40.4% | 48.2% | 40.3% | |
| Return on Assets | -32.4% | -125.1% | -34.4% | |
| Return on Inv Capital | 43.1% | 44.8% | 41.9% | |
| Liquidity | ||||
| Current Ratio | 25.57x | 2.23x | 12.67x | |
| Quick Ratio | 25.57x | 2.23x | 12.67x | |
| Cash Ratio | 9.98x | 2.09x | 11.23x | |
| Leverage | ||||
| Debt / Equity | -0.00x | -0.06x | -0.02x | |
| Equity Multiplier | -1.25x | -0.39x | -1.17x | |
| Efficiency | ||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | |
| Effective Tax Rate | -0.0% | -0.0% | -0.0% | |
| Op CF / Net Income | 0.92x | 0.76x | 0.82x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--